Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between ANG Lifesciences IPO and Nouritrans Exim IPO.
ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Nouritrans Exim IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Guiness Corporate Advisors Pvt Ltd | First Overseas Capital Limited |
| Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Nouritrans Exim IPO is up to ₹6.12 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Nouritrans Exim IPO is ₹30.00 per share.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹80.00 per share | ₹30.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 15,00,800 shares | 20,40,000 shares |
| Issue Size Total (Amount) | up to ₹12.01 Cr | up to ₹6.12 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Nouritrans Exim IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Nouritrans Exim IPO is Aug 31, 2017, and Sep 07, 2017, respectively.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Sep 04, 2017 |
| Issue Close | Aug 31, 2017 | Sep 07, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Nouritrans Exim IPO P/E ratio of .
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Nouritrans Exim IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Nouritrans Exim IPO.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 0 shares | 0 shares |
| NII | 7,12,000 shares | 10,20,000 shares |
| RII | 7,12,000 shares | 10,20,000 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 20,40,000 shares |
ANG Lifesciences IPO subscribed in total, whereas Nouritrans Exim IPO subscribed .
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
